Angiogenesis inhibition by angiostatin, endostatin and TNP-470 prevents cyclophosphamide induced cystitis

被引：10

作者：

Beecken W.-D. ^{[1
]}

Engl T. ^{[1
,3
]}

Blaheta R. ^{[1
,3
]}

Bentas W. ^{[1
,3
]}

Achilles E.-G. ^{[4
]}

Jonas D. ^{[1
,3
]}

Shing Y. ^{[5
]}

Camphausen K. ^{[6
]}

机构：

[1] Department of Urology, J.W. Goethe University, Frankfurt Am Main

[2] Department of Urology, J.W. Goethe University, Frankfurt Am Main, Germany

[3] Department of Hepato-biliare Surgery, University of Hamburg, Germany

[4] Lab. Surg. Res. the Dept. of Surg., Children's Hospital, Boston, Massachusetts, USA

[5] Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland, USA

来源：

Angiogenesis | 2004年 / 7卷 / 1期

关键词：

angiogenesis; angiostatin; chemical cystitis; cyclophosphamide; endostatin; inflammatory reactions; TNP-470;

D O I：

10.1023/B:AGEN.0000037334.70257.d2

中图分类号：

学科分类号：

摘要：

Angiogenesis, the induction of vessel growth is involved in numerous physiological and pathological processes. While the anti-tumor effect of angiogenesis inhibitors has been extensively investigated in malignant tumors, there is very little information on the effect of angiogenesis inhibitors on inflammation induced angiogenesis. In this report, we utilized a murine model of acute chemically induced cystitis to investigate the ability of three different angiogenesis inhibitors, angiostatin, endostatin and TNP-470, to inhibit the angiogenesis stimulated by this injury. We demonstrate herein, that prophylactic application of the angiogenesis inhibitors led to a significant reduction of each of the inflammatory parameters that were measured. We conclude that anti-angiogenic therapy with angiostatin, endostatin and TNP-470 inhibits inflammation associated angiogenesis induced in this model. We also propose that anti-angiogenic agents may serve as a valuable addition to a standard cyclophosphamid chemotherapy regimen to help reduce the chemotherapy-related side effects while potentially adding an anti-tumor effect.

引用

页码：69 / 73

页数：4

共 20 条

[1]

Shacter E., Weitzman S.A., Chronic inflammation and cancer, Oncology, 16, pp. 217-226, (2002)

[2]

Giensburg P.M., Dassopoulos T., Ehrenpreis E.D., Thalidomide treatment for refractory Crohn's disease: A review of the history, pharmacological mechanisms and clinical literature, Ann Med, 33, pp. 516-525, (2001)

[3]

Gray K.J., Shenaq S.M., Engelmann U.H., Et al., Use of human amnion for microvascular interpositional grafts, Plast Reconstr Surg, 79, pp. 778-785, (1987)

[4]

Walsh D.A., Hu D.E., Mapp P.I., Et al., Innervation and neurokinin receptors during angiogenesis in the rat sponge granuloma, Histochem J, 28, pp. 759-769, (1996)

[5]

Assreuy A.M.S., Martins G.J., Moreira M.E.F., Et al., Prevention of cyclophosphamide-induced hemorrhagic cystitis by glucose-mannose binding plant lectins, J Urol, 161, pp. 1988-1993, (1999)

[6]

Hanahan D., Folkman J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, pp. 353-363, (1996)

[7]

Rak J.W., St. Croix B.D., Kerbel R.S., Consequences of angiogenesis for tumor progression, metastasis, and cancer therapy, Anticancer Drugs, 6, pp. 3-18, (1995)

[8]

Griffioen A.W., Molema G., Angiogenesis: Potentials for pharmacologie intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation, Pharm Rev, 52, pp. 237-268, (2000)

[9]

Appleton I., Brown N.J., Willis D., Et al., The role of vascular endothelial growth factor in a murine chronic granulomatous tissue air pouch model of angiogenesis, J Pathol, 180, pp. 90-94, (1996)

[10]

Assreuy A.M.S., Martins G.J., Moreira M.E.F., Et al., Prevention of cyclophosphamide-induced hemorrhagic cystitis by glucose-mannose binding plant lectins, J Urol, 161, pp. 1988-1993, (1999)

← 1 2 →